Application of Goal Attainment Scale as a patient-centered assessment for cervical dystonia
Objective: To explore the goal attainment scale (GAS) by interviewing the three most disturbing problems and changes after Botulinum toxin A injection in cervical dystonia…Relationship of satisfaction and adherence in remote digital monitoring: Updated results from a clinical drug trial in early Parkinson’s disease
Objective: Extend previous findings from a subset of individuals with early Parkinson’s disease (PD) demonstrating high satisfaction levels with daily remote monitoring with a digital…A Patient-Centered Outcomes Survey in Parkinson’s Disease: Results of Cognitive Pre-Testing
Objective: To validate the Rush Parkinson's Disease Patient-Centered Outcomes Questionnaire (RUSH-PCO-Q). Background: The RUSH-PCO-Q aims to address the lack of patient-centered outcomes in the field…Continuous wavelet transforms to improve the accuracy of motor assessments of Parkinson’s disease
Objective: We sought to develop a protocol to utilize continuous wavelet transforms (CWTs) to rate the severity of movements to obtain optimal classifications of PD.…Development of a quality-of-life (QoL) questionnaire for hereditary spastic paraplegia (HSP) patients and caregivers.
Objective: Patient reported outcomes like “Health-Related Quality of Life” are one of the key outcome parameters of clinical studies. The aim of this project within…Socio-economic factors influencing Parkinson’s disease self-management
Objective: To identify the socioeconomical factors associated with self-management Parkinson’s disease (PD). Background: Understanding and evaluating how PD patients manage their disease is paramount to…A modified Delphi panel to establish a threshold of meaningful progression on MDS-UPDRS Part III
Objective: To establish a threshold for meaningful progression on MDS-UPDRS Part III in an early-stage Parkinson's disease (PD) population (Hoehn & Yahr [H&Y] Stage I–II)…Updated Parkinson’s disease motor subtypes classification and correlation to CSF HVA and 5-HIAA levels
Objective: To update a motor subtypes classification using the MDS-UPDRS and determine if CSF neurotransmitter profiles (HVA and 5-HIAA) are different between MDS-UPDRS subtypes in…Clinically interpretable severity estimation of facial expression impairment in Parkinson’s disease
Objective: To develop a scalable and interpretable computer-vision based algorithm to measure the severity of facial impairment in Parkinson’s disease. Background: Neurological disorders frequently manifest…Blood microRNA-7 as a Progression Biomarker in Parkinson’s disease
Objective: This study investigates the use of microRNA-7-5p (miR-7-5p) as a potential biomarker for Parkinson’s disease (PD) progression. Background: MiR-7-5 is a microRNA that regulates…
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 35
- Next Page »